Skip to main content
. 2017 Jul 19;14(9):853–861. doi: 10.7150/ijms.19638

Table 3.

Pilot study on peripheral blood mononuclear cells adrenoceptor mRNA expression

Central obesity Ratio Yes/No
No Yes
n 5 10
F/M 2/3 8/2
Age 31 ± 3 40 ± 3
BMI 21.1 ± 0.7 30.1 ± 2.4
AR subtype
α1A 6.95 x 10-9 ± 1.45 x 10-9 6.87 x 10-9 ± 4.63 x 10-10 0.99
α1B 1.11 x 10-7 ± 2.02 x 10-8 1.56 x 10-7 ± 3.66 x 10-8 1.41
α1D 7.76 x 10-6 ± 2.09 x 10-6 1.1 x 10-5 ± 2.21 x 10-6 1.42
α2A 3.72 x 10-9 ± 2.89 x 10-9 5.74 x 10-9 ± 1.47 x 10-9 1.54
α2B not detected not detected
α2C 4.39 x 10-9 ± 6.76 x 10-10 4.57 x 10-9 ± 3.69 x 10-10 1.04
β1 not detected not detected
β2 7.54 x 10-5 ± 5.98 x 10-5 3.14 x 10-5 ± 1.84 x 10-5 0.42
β3 2.56 x 10-8 ± 5.51 x 10-9 2.13 x 10-8 ± 5.51 x 10-9 0.83

Analysis of AR mRNA expression in peripheral blood mononuclear cells in a subgroup of subjects without and with central obesity selected as those having highest or lowest BMI values. Data are presented as mean ± standard error of the mean (SEM). F/M, female male ratio; BMI, body mass index; AR, adrenoceptor. For details see Methods.